NasdaqCM:LQDAPharmaceuticals
Assessing Liquidia (LQDA) Valuation After Recent Share Price Moves And Growth Expectations
Liquidia (LQDA) has drawn investor attention after recent share price moves, with the stock closing at US$38.55. The company focuses on therapies for rare cardiopulmonary diseases and generates all reported revenue in the United States.
See our latest analysis for Liquidia.
Despite a 4.39% one day share price pullback, Liquidia’s recent 7 day and 30 day share price returns of 2.31% and 5.16% sit alongside a very large 1 year total shareholder return, suggesting momentum has been building...